Aptamer-Conjugated Nanoparticles for Cancer Cell Detection

被引:144
作者
Medley, Colin D. [1 ,2 ,3 ]
Bamrungsap, Suwussa [1 ,2 ,3 ]
Tan, Weihong [1 ,2 ,3 ]
Smith, Joshua E. [1 ,2 ,3 ,4 ]
机构
[1] Univ Florida, Dept Chem, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA
[2] Univ Florida, Shands Canc Ctr, UF Genet Inst, Gainesville, FL 32611 USA
[3] Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA
[4] Armstrong Atlantic State Univ, Dept Chem & Phys, Savannah, GA 31419 USA
关键词
GLIOBLASTOMA-MULTIFORME PATIENTS; NUCLEIC-ACID APTAMERS; MOLECULAR RECOGNITION; LIVE CELLS; COLLECTION; MEDICINE; MARKERS; SELEX;
D O I
10.1021/ac102263v
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Aptamer-conjugated nanoparticles (ACNPs) have been used for a variety of applications, particularly dual nanoparticles for magnetic extraction and fluorescent labeling. In this type of assay, silica-coated magnetic and fluorophore-doped silica nanoparticles are conjugated to highly selective aptamers to detect and extract targeted cells in a variety of matrixes. However, considerable improvements are required in order to increase the selectivity and sensitivity of this two-particle assay to be useful in a clinical setting. To accomplish this, several parameters were investigated, including nanoparticle size, conjugation chemistry, use of multiple aptamer sequences on the nanoparticles, and use of multiple nanoparticles with different aptamer sequences. After identifying the best-performing elements, the improvements made to this assay's conditional parameters were combined to illustrate the overall enhanced sensitivity and selectivity of the two particle assay using an innovative multiple aptamer approach, signifying a Critical, feature in the advancement of this technique.
引用
收藏
页码:727 / 734
页数:8
相关论文
共 19 条
[1]   Nucleic acid aptamers in cancer medicine [J].
Cerchia, L ;
Hamm, J ;
Libri, D ;
Tavitian, B ;
de Franciscis, V .
FEBS LETTERS, 2002, 528 (1-3) :12-16
[2]   Molecular recognition of small-cell lung cancer cells using aptamers [J].
Chen, Hui William ;
Medley, Colin D. ;
Sefah, Kwame ;
Shangguan, Dihua ;
Tang, Zhiwen ;
Meng, Ling ;
Smith, Josh E. ;
Tan, Weihong .
CHEMMEDCHEM, 2008, 3 (06) :991-1001
[3]   Aptamers Generated from Cell-SELEX for Molecular Medicine: A Chemical Biology Approach [J].
Fang, Xiaohong ;
Tan, Weihong .
ACCOUNTS OF CHEMICAL RESEARCH, 2010, 43 (01) :48-57
[4]   OLIGONUCLEOTIDES AS RESEARCH, DIAGNOSTIC, AND THERAPEUTIC AGENTS [J].
GOLD, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (23) :13581-13584
[5]   Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients [J].
Heimberger, AB ;
Hlatky, R ;
Suki, D ;
Yang, D ;
Weinberg, J ;
Gilbert, M ;
Sawaya, R ;
Aldape, K .
CLINICAL CANCER RESEARCH, 2005, 11 (04) :1462-1466
[6]   The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients [J].
Heimberger, Amy B. ;
Sampson, John H. .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (08) :1087-1098
[7]   Biochemistry - Adaptive recognition by nucleic acid aptamers [J].
Hermann, T ;
Patel, DJ .
SCIENCE, 2000, 287 (5454) :820-825
[8]   Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells [J].
Herr, Joshua K. ;
Smith, Joshua E. ;
Medley, Colin D. ;
Shangguan, Dihua ;
Tan, Weihong .
ANALYTICAL CHEMISTRY, 2006, 78 (09) :2918-2924
[9]   Prognostic impact of molecular markers in a series of 220 primary glioblastomas [J].
Houillier, C ;
Lejeune, J ;
Benouaich-Amiel, A ;
Laigle-Donadey, F ;
Criniere, E ;
Mokhtari, K ;
Thillet, J ;
Delaffre, JY ;
Hoang-Xuan, K ;
Sanson, M .
CANCER, 2006, 106 (10) :2218-2223
[10]   Human herpesvirus 6 and multiple sclerosis: Systemic active infections in patients with early disease [J].
Knox, KK ;
Brewer, JH ;
Henry, JM ;
Harrington, DJ ;
Carrigan, DR .
CLINICAL INFECTIOUS DISEASES, 2000, 31 (04) :894-903